Developing a New Treatment for Motor Neuron Disease

Alsonex is focused on developing new treatments for neurodegenerative disease such as Motor Neuron Disease. The company was founded in 2014 from research being undertaken at the University of Queensland and elsewhere into the cause of neuroinflammation and its role in causing neurodegenerative disease.

Alsonex is committed to being a part of the solution to slowing or reversing neurodegenerative diseases such as Parkinson's Disease, Alzheimer's Disease, Huntington's Disease and Motor Neuron Disease. Enquiries regarding the status of the company's research are welcome — the Alsonex team is glad to answer questions about MND or any of the products currently in development. Through quality research and development, the company's overarching goal is to make a positive impact on the significant challenges faced by people with neurodegenerative disease.